View Item 

Show simple item record

Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials
dc.contributor.authorJavier-Desloges, Juan
dc.contributor.authorNelson, Tyler J.
dc.contributor.authorMurphy, James D.
dc.contributor.authorMcKay, Rana R.
dc.contributor.authorPan, Elizabeth
dc.contributor.authorParsons, J. Kellogg
dc.contributor.authorKane, Christopher J.
dc.contributor.authorKader, A. Karim
dc.contributor.authorDerweesh, Ithaar H.
dc.contributor.authorNodora, Jesse
dc.contributor.authorPatel, Sandip P.
dc.contributor.authorMartinez, Maria Elena
dc.contributor.authorRose, Brent S.
dc.date.accessioned2022-02-07T20:26:14Z
dc.date.available2023-03-07 15:26:13en
dc.date.available2022-02-07T20:26:14Z
dc.date.issued2022-02-15
dc.identifier.citationJavier-Desloges, Juan ; Nelson, Tyler J.; Murphy, James D.; McKay, Rana R.; Pan, Elizabeth; Parsons, J. Kellogg; Kane, Christopher J.; Kader, A. Karim; Derweesh, Ithaar H.; Nodora, Jesse; Patel, Sandip P.; Martinez, Maria Elena; Rose, Brent S. (2022). "Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials." Cancer (4): 770-777.
dc.identifier.issn0008-543X
dc.identifier.issn1097-0142
dc.identifier.urihttps://hdl.handle.net/2027.42/171620
dc.publisherSurveillance, Epidemiology, and End Results Program
dc.publisherWiley Periodicals, Inc.
dc.subject.otherbreast cancer
dc.subject.otherclinical trials
dc.subject.othercolorectal cancer
dc.subject.otherdisparities
dc.subject.otherlung cancer
dc.subject.otherprostate cancer
dc.titleDisparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/171620/1/cncr33991.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/171620/2/cncr33991_am.pdf
dc.identifier.doi10.1002/cncr.33991
dc.identifier.sourceCancer
dc.identifier.citedreferenceNational Institutes of Health. Amendment: NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research. Accessed February 5, 2021. https://grants.nih.gov/grants/guide/notice- files/NOT- OD- 18- 014.html
dc.identifier.citedreferenceMurthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race- , sex- , and age- based disparities. JAMA. 2004; 291: 2720 - 2726. doi: 10.1001/jama.291.22.2720
dc.identifier.citedreferenceKwiatkowski K, Coe K, Bailar JC, Swanson GM. Inclusion of minorities and women in cancer clinical trials, a decade later: have we improved? Cancer. 2013; 119: 2956 - 2963. doi: 10.1002/cncr.28168
dc.identifier.citedreferenceHeller C, Balls- Berry JE, Nery JD, et al. Strategies addressing barriers to clinical trial enrollment of underrepresented populations: a systematic review. Contemp Clin Trials. 2014; 39: 169 - 182. doi: 10.1016/j.cct.2014.08.004
dc.identifier.citedreferenceLewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol Off J Am Soc Clin Oncol. 2003; 21: 1383 - 1389. doi: 10.1200/JCO.2003.08.010
dc.identifier.citedreferenceLudmir EB, Mainwaring W, Lin TA, et al. Factors associated with age disparities among cancer clinical trial participants. JAMA Oncol. 2019; 5: 1769. doi: 10.1001/jamaoncol.2019.2055
dc.identifier.citedreferenceDuma N, Vera Aguilera J, Paludo J, et al. Representation of minorities and women in oncology clinical trials: review of the past 14 years. J Oncol Pract. 2017; 14: e1 - e10. doi: 10.1200/JOP.2017.025288
dc.identifier.citedreferenceHeiney SP, Adams SA, Wells LM, Johnson H. Evaluation of conceptual framework for recruitment of African American patients with breast cancer. Oncol Nurs Forum. 2010; 37: E160 - E167. doi: 10.1188/10.ONF.E160- E167
dc.identifier.citedreferenceChen MS, Lara PN, Dang JHT, Paterniti DA, Kelly K. Twenty years post- NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials. Cancer. 2014; 120 ( suppl 7 ): 1091 - 1096. doi: 10.1002/cncr.28575
dc.identifier.citedreferenceMcCaskill- Stevens W, Pinto H, Marcus AC, et al. Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. J Clin Oncol. 1999; 17: 1029 - 1039. doi: 10.1200/JCO.1999.17.3.1029
dc.identifier.citedreferenceGhebre RG, Jones LA, Wenzel J, Martin MY, Durant R, Ford JG. State- of- the- science of patient navigation as a strategy for enhancing minority clinical trial accrual. Cancer. 2014; 120: 1122 - 1130. doi: 10.1002/cncr.28570
dc.identifier.citedreferenceCommon Cancer Types - National Cancer Institute. Published April 21, 2015. Accessed March 30, 2021. https://www.cancer.gov/types/common- cancers
dc.identifier.citedreferenceHenley SJ, Singh SD, King J, Wilson RJ, O- Neil ME, Ryerson AB. Invasive cancer incidence and survival - United States, 2013. MMWR Morb Mortal Wkly Rep. 2017; 66: 69 - 75. doi: 10.15585/mmwr.mm6603a1
dc.identifier.citedreferenceCenters for Disease Control. National Program of Cancer Registries (NPCR). Published March 31, 2021. Accessed April 8, 2021. https://www.cdc.gov/cancer/npcr/index.htm
dc.identifier.citedreferenceSEER Incidence Data, 1975- 2017. Surveillance, Epidemiology, and End Results Program. Accessed March 30, 2021. https://seer.cancer.gov/data/
dc.identifier.citedreferenceCenters for Disease Control. United States Cancer Statistics. Published March 10, 2021. Accessed April 8, 2021. https://www.cdc.gov/cancer/uscs/index.htm
dc.identifier.citedreferenceNational Cancer Institute. NCI’s National Clinical Trials Ne2rk (NCTN). Published May 29, 2014. Accessed March 30, 2021. https://www.cancer.gov/research/infrastructure/clinical- trials/nctn
dc.identifier.citedreferenceUnited States Department of Justice. Freedom of Information Act (FOIA) home page. Accessed March 30, 2021. https://www.foia.gov/
dc.identifier.citedreferenceNational Cancer Institute NCI Community Oncology Research Program (NCORP). Accessed February 5, 2021. https://ncorp.cancer.gov/
dc.identifier.citedreferenceGresham G, Meinert JL, Gresham AG, Meinert CL. Assessment of trends in the design, accrual, and completion of trials registered in ClinicalTrials.gov by sponsor type, 2000- 2019. JAMA Netw Open. 2020; 3: e2014682. doi: 10.1001/jamanetworkopen.2020.14682
dc.identifier.citedreferenceRivers DA, Pal T, Vadaparampil ST, Adams LA, Dash- Pitts L, Quinn GP. A community- academic partnership to explore informational needs of African American women as a primer for cancer clinical trial recruitment. Ethn Health. 2019; 24: 679 - 693. doi: 10.1080/13557858.2017.1367762
dc.identifier.citedreferenceRamasubbu K, Gurm H, Litaker D. Gender bias in clinical trials: do double standards still apply? J Womens Health Gend Based Med. 2001; 10: 757 - 764. doi: 10.1089/15246090152636514
dc.identifier.citedreferenceJavier- DesLoges JF, Segal D, Khan A, et al. Urology residency training in medically underserved areas through the integration of a federally qualified health center rotation. Urology. 2021; 149: 52 - 57. doi: 10.1016/j.urology.2020.11.057
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncr33991.pdf
Size:
206.3KB
Format:
PDF
View/Open
Name:
cncr33991_am.pdf
Size:
306.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.